ENTEROME
Enterome is an integrated company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics.Enterome is focused on the identification of the bioactive molecules that are differentially expressed, secreted and regulated by the gut microbiome, which play a central role in the regulation of key aspects of human physiology and the immune system.
ENTEROME
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2011-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.enterome.com
Total Employee:
11+
Status:
Active
Contact:
33 1 76 21 58 19
Email Addresses:
[email protected]
Total Funding:
128.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Series E - ENTEROME
Principia SGR
Principia SGR investment in Series E - ENTEROME
Nestlé Health Science
Nestlé Health Science investment in Series E - ENTEROME
Omnes Capital
Omnes Capital investment in Series E - ENTEROME
Health for Life Capital fund
Health for Life Capital fund investment in Series E - ENTEROME
Takeda
Takeda investment in Series E - ENTEROME
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Debt Financing - ENTEROME
Principia SGR
Principia SGR investment in Debt Financing - ENTEROME
Nestlé Health Science
Nestlé Health Science investment in Debt Financing - ENTEROME
Seventure Partners
Seventure Partners investment in Debt Financing - ENTEROME
Official Site Inspections
http://www.enterome.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.49 K
- Host name: 217-160-0-215.elastic-ssl.ui-r.com
- IP address: 217.160.0.215
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "ENTEROME"
ENTEROME - Crunchbase Company Profile & Funding
Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture …See details»
Enterome | Leukemia and Lymphoma Society
Oct 30, 2023 For more information about Enterome, visit enterome.com. Recent News. ... The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax …See details»
Enterome - LinkedIn
Enterome | 15,399 followers on LinkedIn. Delivering the promise of immunotherapy | Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the ...See details»
Careers - Enterome
Enterome achieved a score of 96/100!! Since 2018, companies with more than fifty employees are required to calculate and publish each year the gender equality index. For the year 2023, Enterome achieved a score of 96 points out …See details»
ENTEROME - Contacts, Employees, Board Members, Advisors
Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. ... Experience the new Crunchbase, powered by AI …See details»
Enterome - Overview, News & Similar companies | ZoomInfo.com
Who is Enterome. Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and im mune …See details»
ENTEROME Company Profile - Office Locations, Competitors
ENTEROME has 5 employees across 2 locations, $129.57 m in total funding, and €2.71 m in annual revenue in FY 2020. See insights on ENTEROME including office locations, …See details»
Enterome - VentureRadar
Enterome’s success is based on its unique ability to identify small proteins and peptides (“effectors”) from gut bacteria that can deliver a therapeutic benefit in humans. Enterome is …See details»
Enterome (France) Funding: €175.8M - Medical Startups
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s …See details»
Enterome
Enterome’s potentially first-in-class drug candidates modulate the immune system by closely mimicking the structure, effect or actions of specific antigens, hormones or cytokines. The Company is presently advancing its proprietary …See details»
Enterome - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 Enterome has raised a total funding of $130M over 7 rounds. Its first funding round was on 2008. Its latest funding round was a Series E round on Jun 25, 2020 for $52.3M. 6 …See details»
Enterome Bioscience - Companies Directory Genopole, Innovation …
Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota. BACKGROUND Enterome is the result of scientific breakthroughs made …See details»
Enterome SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore Enterome SA with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 51 news, Disease Domain:Immune System Diseases, Neoplasms, Nervous System …See details»
Enterome Selected to The Leukemia & Lymphoma Society’s …
Oct 31, 2023 LLS is the only organization featured in the nonprofit category on both Fast Company’s 2022 Brands That Matter list and the 2023 Best Workplaces for Innovators list. …See details»
Enterome - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Enterome is a clinical stage …See details»
Microbiome company Enterome plans $108m raise to fund Phase …
Aug 25, 2023 The company had previously raised EUR 46.3m as part of its Series E round, based on a June 2020 release, while Belichard added that Enterome has raised EUR 116m to …See details»
Embrace Change, Drive Success - SHRM
Let’s make change work for your organization. SHRM Business Offerings. Corporate Membership. Certification. Team Training & Development. Individual & Team Assessments. Events. Take …See details»
Enterome
Jul 18, 2022 Enterome and Nestlé Health Science will co-develop Enterome’s lead EndoMimics™ compound, EB1010, a potent local inducer of IL-10 targeting food allergies and …See details»
Enterome
Enterome uses non-self bacterial peptides to target tumors which allow us to tap into a pool of memory T cells with pre-existing immune response; Excellent immunogenicity Enterome uses …See details»
Enterome
Enterome has developed a target-driven approach to drug discovery based on a unique and progressive understanding of the human gut microbiome and its effects on the immune …See details»